Dilip Shanghvi
About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us
Dilip Shanghvi
Managing Director
Sun Pharmaceutical Industries Limited

Dilip Shanghvi is the Managing Director of Sun Pharmaceutical Industries Ltd. (Market capitalization of USD 30 billion as of February 2016). Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world. Sun Pharma's global presence is supported by 49 manufacturing facilities spread across 6 continents, R&D centers across the globe and a multi-cultural workforce comprising over 50 nationalities. The consolidated revenues 2015 were at US$ 4.5 billion, of which US contributed US$ 2.2 billion. In India, the company enjoys leadership with 30 brands featuring amongst top 300 pharmaceutical brands of the country. Its footprint across emerging markets covers over 100 countries and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst top 10 across 4 global markets. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising 2000 scientists and R&D investments of over 7% of annual revenues. Sun Pharma, as a start-up, had a first year sales of USD 0.02 million in 1983. Mr. Shanghvi is also Chairman and Managing Director of Sun Pharmaceutical Advanced Research Company Ltd. (SPARC, market capitalization of over USD 800 million as of February 2016); an international pharmaceutical company engaged in research and development of drugs and delivery systems. SPARC, created in 2007 by the demerger of innovative business from Sun Pharma, is the first pure R&D company to be listed on Indian stock exchanges. Mr. Shanghvi also owns, in his individual capacity, several private investment companies that invest in emerging technology areas. He is a former President of Indian Pharmaceutical Alliance (IPA).

Awards and Recognitions

  • PADMA SHRI – 2016 (Fourth highest civilian award - Govt. of India)
  • NDTV Business Leadership Award - Pharmaceutical – 2016
  • Forbes Entrepreneur for the year – 2014
  • Outstanding Business Leader of the Year - 2014, CNBC – TV18
  • The Economic Times Business Leader of the Year, 2014
  • AIMA (All India Management Association) - JRD TATA Corporate Leadership Award, 2014
  • Ranked by Forbes amongst the world's most innovative companies. (2014), (2012). Ranked by Forbes amongst Asia's Fab 50 companies (2013)
  • Business Standard Company of the Year, 2013
  • The Economic Times Company of the Year, 2013
  • NDTV Profit Business Leadership Award 2012- pharmaceuticals
  • IBLA Outstanding Company of the year – 2012, CNBC – TV18
  • Business India –Businessman of the year, 2011
  • CNN IBN Indian of the Year, 2011- Business
  • Ernst & Young Entrepreneur of the Year, India - 2010
  • Entrepreneur of the Year - The Economic Times, 2008
  • CEO of the Year- Business Standard, 2008
  • First Generation Entrepreneur of the Year- CNBC – TV18 IBLA- 2007
  • Ernst & Young Entrepreneur of the Year, 2005 - Healthcare and Life Sciences category
© 2007 - USA India Chamber of Commerce Home | About us | | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | | Legal | Contact us